Literature DB >> 26661687

Role of Automatic Wireless Remote Monitoring Immediately Following ICD Implant: The Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) Trial.

Niraj Varma1, Andrew E Epstein2, Robert Schweikert3, Justin Michalski4, Charles J Love5.   

Abstract

INTRODUCTION: The incidence of unscheduled encounters and problem occurrence between ICD implant and first in-person evaluation (IPE) recommended at 12 weeks is unknown. Automatic remote home monitoring (HM) may be useful in this potentially unstable period. METHODS AND
RESULTS: ICD patients were randomized 2:1 to HM enabled post-implant (n = 908) or to conventional monitoring (CM; n = 431). Groups were compared between implant and prior to first scheduled IPE for IPE incidence, causes, and actionability (reprogramming, system revision, medication changes) and event detection time. HM and CM patients were similar (mean age 63 years, 72% male, LVEF 29%, primary prevention 73%, DDD 57%). In the post-implant interval assessed (HM 100 ± 21.3 days vs. CM 101 ± 20.8 days, P = 0.54), 85.4% (776/908) HM patients and 87.7% CM (378/431) patients had no cause for IPE (P = 0.31). When IPE occurred, actionability in HM (64/177 [36.2%]) was greater versus CM (15/62 [24.2%], P = 0.12). Actionable items were discovered sooner with HM (P = 0.025). Device reprogramming or lead revision was triggered following 53/177 (29.9%) IPEs in HM versus 9/62 (14.5%) in CM (P = 0.018). Arrhythmia detection was enhanced by HM: 276 atrial and ventricular episodes were detected in 135 follow-ups in contrast to CM (65 episodes at 17 IPEs). More silent arrhythmic episodes were discovered by HM (7.2% vs. 1.5% [P = 0.15]). Since 27/42 (64.3%) IPEs driven by HM alerts were actionable, event notification was a valuable method for problem detection. Importantly, HM did not increase incidence of non-actionable IPEs (P = 0.72).
CONCLUSION: Activation of automatic remote monitoring should be encouraged soon post-ICD implant.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  defibrillators; follow-up; patient monitoring; remote monitoring

Mesh:

Year:  2016        PMID: 26661687     DOI: 10.1111/jce.12895

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  3 in total

1.  Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation.

Authors:  Suneet Mittal; Jonathan P Piccini; Jeff Snell; Julie B Prillinger; Nirav Dalal; Niraj Varma
Journal:  J Interv Card Electrophysiol       Date:  2016-02-10       Impact factor: 1.900

2.  INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact).

Authors:  Claudius Hansen; Christian Loges; Karlheinz Seidl; Frank Eberhardt; Herbert Tröster; Krum Petrov; Gerian Grönefeld; Peter Bramlage; Frank Birkenhauer; Christian Weiss
Journal:  BMC Cardiovasc Disord       Date:  2018-06-28       Impact factor: 2.298

Review 3.  Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2018-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.